abstract |
The present invention relates to a method of treating cancer selected from ovarian cancer, lung cancer and colon cancer using an agent capable of inhibiting the expression of Leukemia Inhibitory Factor (LIF) and / or blocking the activity of LIF . The present invention also relates to a method for the treatment of ovarian cancer, lung cancer or colon cancer which can be tailored for patients with ovarian cancer, lung cancer or colon cancer and can be treated using agents capable of inhibiting the expression of LIF and / Or colorectal cancer in a patient suffering from cancer. |